In CAV1high MDA-MB-231 cells, CAV1 knockdown did not significantly aggravate the inhibitory ability of ADQ in the presence of paclitaxel, suggesting that ADQ might target CAV1 to chemosensitize breast cancer (Figure 11A). The gene discussed is CAV1; the disease is breast carcinoma.